• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Claudin18.who? Examining biomarker overlap and outcomes in claudin18.2-positive gastroesophageal adenocarcinomas.

作者信息

Klempner S J, Janjigian Y Y, Wainberg Z A

机构信息

Department of Medicine, Division of Hematology-Oncology, Massachusetts General Hospital, Boston, USA.

Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA; Department of Medicine, Weill Cornell Medical College, New York, USA.

出版信息

ESMO Open. 2023 Apr;8(2):100778. doi: 10.1016/j.esmoop.2022.100778. Epub 2023 Feb 13.

DOI:10.1016/j.esmoop.2022.100778
PMID:36791669
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9958250/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c6/9958250/d5489a2c6a79/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c6/9958250/d5489a2c6a79/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6c6/9958250/d5489a2c6a79/gr1.jpg

相似文献

1
Claudin18.who? Examining biomarker overlap and outcomes in claudin18.2-positive gastroesophageal adenocarcinomas.紧密连接蛋白18.2是什么？探究紧密连接蛋白18.2阳性胃食管腺癌中的生物标志物重叠情况及预后
ESMO Open. 2023 Apr;8(2):100778. doi: 10.1016/j.esmoop.2022.100778. Epub 2023 Feb 13.
2
[Adenocarcinomas of the distal esophagus. Adenocarcinomas of the cardia].[食管远端腺癌。贲门腺癌]
Cancer Radiother. 2001 Nov;5 Suppl 1:80s-83s.
3
A 14-Year Study of 398 Esophageal Adenocarcinomas Diagnosed Among 156,256 EGDs Performed at Two Large Hospitals: An Inlet Patch Is Proposed as a Significant Risk Factor for Proximal Esophageal Adenocarcinoma.在两家大医院进行的 156256 次内镜检查中诊断出 398 例食管腺癌：14 年研究结果表明，入口补丁被认为是近端食管腺癌的一个重要危险因素。
Dig Dis Sci. 2018 Feb;63(2):452-465. doi: 10.1007/s10620-017-4878-2. Epub 2017 Dec 16.
4
Cytopathological features of gastroesophageal junction adenocarcinoma with enteroblastic differentiation and histopathological correlation.具有成肠细胞分化的胃食管交界腺癌的细胞病理学特征及组织病理学相关性
Cytopathology. 2023 May;34(3):250-253. doi: 10.1111/cyt.13198. Epub 2022 Dec 24.
5
Use of novel autoantibody and cancer-related protein arrays for the detection of esophageal adenocarcinoma in serum.使用新型自身抗体和癌症相关蛋白质阵列检测血清中的食管腺癌。
J Thorac Cardiovasc Surg. 2008 Jul;136(1):199-204. doi: 10.1016/j.jtcvs.2008.01.012. Epub 2008 May 22.
6
Pedunculated Upper Esophageal Adenocarcinoma in Lynch Syndrome.林奇综合征中的带蒂食管上段腺癌
Clin Gastroenterol Hepatol. 2019 Apr;17(5):A20. doi: 10.1016/j.cgh.2018.06.008. Epub 2018 Aug 4.
7
Adenocarcinoma of the esophagus: controversies and consensus.食管腺癌：争议与共识
Chin Clin Oncol. 2017 Oct;6(5):52. doi: 10.21037/cco.2017.09.02.
8
An unusual case of oesophageal adenocarcinoma presenting with subcutaneous metastases.一例罕见的食管腺癌伴皮下转移病例。
J Gastrointest Cancer. 2014 Dec;45 Suppl 1:175-7. doi: 10.1007/s12029-014-9614-y.
9
Introduction: Esophageal Adenocarcinoma: Updates of Current Status.引言：食管腺癌：现状更新
Methods Mol Biol. 2018;1756:1-6. doi: 10.1007/978-1-4939-7734-5_1.
10
Staging esophageal adenocarcinoma.食管腺癌的分期
Semin Gastrointest Dis. 2003 Jul;14(3):146-54.

引用本文的文献

1
Claudin18.2-Targeted SPECT/CT Imaging for Gastric Cancer: Preclinical Evaluation and Clinical Translation of the Tc-Labeled Nanobody (PHG102) Radiotracer.Claudin18.2靶向的SPECT/CT成像用于胃癌：锝标记纳米抗体（PHG102）放射性示踪剂的临床前评估与临床转化
ACS Pharmacol Transl Sci. 2024 Jul 20;7(8):2465-2475. doi: 10.1021/acsptsci.4c00280. eCollection 2024 Aug 9.
2
Synthesis, preclinical evaluation and pilot clinical translation of [Ga]Ga-PMD22, a novel nanobody PET probe targeting CLDN18.2 of gastrointestinal cancer.[Ga]Ga-PMD22 的合成、临床前评估及初步临床转化，一种新型针对胃肠道癌 CLDN18.2 的纳米抗体 PET 探针。
Eur J Nucl Med Mol Imaging. 2024 Oct;51(12):3731-3743. doi: 10.1007/s00259-024-06808-5. Epub 2024 Jun 27.
3
Molecular alterations in claudin 18 suppressed and non-suppressed gastric adenocarcinomas to guide targeted therapies.紧密连接蛋白18表达受抑与未受抑的胃腺癌中的分子改变以指导靶向治疗
Tissue Barriers. 2025 Jan 2;13(1):2348852. doi: 10.1080/21688370.2024.2348852. Epub 2024 May 7.
4
Claudin 18.2 as a New Biomarker in Gastric Cancer-What Should We Know?Claudin 18.2作为胃癌的新型生物标志物——我们应该了解什么？
Cancers (Basel). 2024 Feb 5;16(3):679. doi: 10.3390/cancers16030679.
5
Claudin18.2 in Advanced Gastric Cancer.Claudin18.2与晚期胃癌
Cancers (Basel). 2023 Dec 7;15(24):5742. doi: 10.3390/cancers15245742.